Joseph W. Strohbach

Joseph W. Strohbach

Auto-generated profile, based on publicly available information

Joseph W. Strohbach

Medicine Design, Pfizer, Cambridge, MA 02139, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Science
Verified
Journal Article
Closed access
FOFabian Offensperger
Fabian Offensperger
GTGary Tin
Gary Tin
MDMiquel Duran-Frigola
Miquel Duran-Frigola
EHElisa Hahn
Elisa Hahn
SDSarah Dobner
Sarah Dobner
GWGeorg E. Winter
Georg E. Winter
Chemical modulation of proteins enables a mechanistic understanding of biology and represents the foundation of most therapeutics. However, despite decades of research, 80% of the human proteome lacks functional ligands. Chemical proteomics has advanced fragment-based ligand discovery toward cellular systems, but throughput limitations have stymied the scalable identification of fragment-protein interactions. We report proteome-wide maps of protein-binding propensity for 407 structurally diverse small-molecule fragments. We verified that identified interactions can be advanced to active chemical probes of E3 ubiquitin ligases, transporters, and kinases. Integrating machine learning binary classifiers further enabled interpretable predictions of fragment behavior in cells. The resulting resource of fragment-protein interactions and predictive models will help to elucidate principles of molecular recognition and expedite ligand discovery efforts for hitherto undrugged proteins.

1 April 1993 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
STSuvit Thaisrivongs
Suvit Thaisrivongs
STSteve R. Turner
Steve R. Turner
JSJoseph W. Strohbach
Joseph W. Strohbach
RTRuth E. TenBrink
Ruth E. TenBrink
WTW. Gary Tarpley
W. Gary Tarpley
WHW. Jeffrey Howe
W. Jeffrey Howe